This HTML5 document contains 181 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n9http://dx.doi.org/10.1371/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q35087745
rdf:type
wikibase:Item
schema:description
научни чланак 2014 թվականի փետրվարին հրատարակված գիտական հոդված επιστημονικό άρθρο artículo científico publicado en 2014 ২০১৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ наукова стаття, опублікована в лютому 2014 2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած мақолаи илмӣ wissenschaftlicher Artikel vitskapeleg artikkel 2014年论文 artikull shkencor vetenskaplig artikel naučni članak 2014年論文 מאמר מדעי บทความทางวิทยาศาสตร์ scientific article 2014年论文 article scientifique (publié 2014) 2014 nî lūn-bûn vedecký článok teaduslik artikkel 2014年論文 scienca artikolo სამეცნიერო სტატია articolo scientifico 2014年论文 سائنسی مضمون 2014年の論文 tieteellinen artikkeli article científic научни чланак artículu científicu espublizáu en 2014 научна статия мақолаи илмӣ articol științific 2014年论文 artikulong pang-agham videnskabelig artikel (udgivet 2014) bài báo khoa học 2014년 논문 tudományos cikk 2014年論文 artigo científico (publicado na 2014) mokslinis straipsnis مقالهٔ علمی 2014年論文 artykuł naukowy vědecký článek 2014年论文 artigo científico (publicado na 2014) bilimsel makale 2014年论文 artigo científico научная статья wetenschappelijk artikel article scientific 2014年論文 vitenskapelig artikkel مقالة علمية
p:P577
wds:Q35087745-E5A3AB12-A2F8-4E5D-9124-BA1D6BDF1EAC
wdt:P577
2014-02-04T00:00:00Z
p:P407
wds:Q35087745-E0DF4E12-5FB3-4B2C-944E-FD2AF6D88FF6
wdt:P407
wd:Q1860
p:P2860
wds:Q35087745-F72BFB26-9267-42CA-AD76-A3D535EC97D7 wds:Q35087745-FEAD43A7-AA7F-407D-A03F-03E717C08FA7 wds:Q35087745-EACF78F7-5F39-408B-90A2-E1773F3A3E7C wds:Q35087745-CAC5DC09-B83B-4890-B933-6C3D0ED1D5FC wds:Q35087745-D93B2A6F-3702-4173-9869-C158FE8165D9 wds:Q35087745-1B495CDE-A425-4A3C-9C7D-3975F624236B wds:Q35087745-29AE20DE-63EB-46E5-BC33-F5EB7B263475 wds:Q35087745-0818D636-EE09-4F62-BF3A-33692039D011 wds:Q35087745-0E104A9C-54D2-40A5-9941-E0524ACDAA73 wds:Q35087745-1703E7AF-21AD-42DA-BAAF-487F0BBC19B0 wds:Q35087745-044B1584-54D3-4BCB-AED1-A63F70100463 wds:Q35087745-6555E8D7-6882-4DB0-A786-4D60E1E57174 wds:Q35087745-734F7C30-0064-4F82-B289-02E1DD783625 wds:Q35087745-541836F1-E211-4A31-9AAC-C5D3E0DBA7CC wds:Q35087745-604F31E9-9CE0-4F1C-99AE-FEC4F531DF2B wds:Q35087745-439F9F15-94F5-46C7-9505-95423CF729C3 wds:Q35087745-51E3B841-BB74-44C1-B685-C69A91FEBBBB wds:Q35087745-B9DB0913-BFE5-4822-8AF4-39DD5E449D8A wds:Q35087745-C064F1A9-295E-4E6E-8C2B-3E3C3A230A6D wds:Q35087745-C37BA1D3-951E-4AAD-9958-9257649EFA0B wds:Q35087745-AB3E267E-BA1C-4E7E-A08F-44EA10864C10 wds:Q35087745-B04861D5-744C-4A3C-AEAA-892FA064BB57 wds:Q35087745-B32ABFFE-8CEC-45FD-88D2-E7FE01F2A762 wds:Q35087745-A4BCF464-609C-440E-BBFE-198B36B1A3E9 wds:Q35087745-A7648A34-F1F9-49EB-ABC6-95B971DD699A wds:Q35087745-A97E9D3A-3F2E-4F06-97FD-A7EE0C72011A wds:Q35087745-87E280DD-B157-4A8B-8D1C-DCCD8F366476 wds:Q35087745-8CCED8C1-82FB-4877-A76E-7AB3CEC9E64B wds:Q35087745-8D63BD56-A0BD-4BD6-BC43-1C0CCC869C5F
wdt:P2860
wd:Q43682173 wd:Q36706534 wd:Q33448696 wd:Q43858400 wd:Q45739763 wd:Q40425001 wd:Q44580891 wd:Q46500002 wd:Q44838445 wd:Q44644287 wd:Q34289633 wd:Q44072600 wd:Q46364266 wd:Q42937138 wd:Q73854074 wd:Q38478387 wd:Q37706104 wd:Q24802369 wd:Q48331724 wd:Q45924444 wd:Q82849742 wd:Q50788638 wd:Q43285218 wd:Q37590842 wd:Q44492237 wd:Q37370783 wd:Q36276879 wd:Q51910874 wd:Q51910877
rdfs:label
Randomised study to assess the efficacy and safety of once-daily etravirine-based regimen as a switching strategy in HIV-infected patients receiving a protease inhibitor-containing regimen. Etraswitch study Randomised study to assess the efficacy and safety of once-daily etravirine-based regimen as a switching strategy in HIV-infected patients receiving a protease inhibitor-containing regimen. Etraswitch study Randomised study to assess the efficacy and safety of once-daily etravirine-based regimen as a switching strategy in HIV-infected patients receiving a protease inhibitor-containing regimen. Etraswitch study
skos:prefLabel
Randomised study to assess the efficacy and safety of once-daily etravirine-based regimen as a switching strategy in HIV-infected patients receiving a protease inhibitor-containing regimen. Etraswitch study Randomised study to assess the efficacy and safety of once-daily etravirine-based regimen as a switching strategy in HIV-infected patients receiving a protease inhibitor-containing regimen. Etraswitch study Randomised study to assess the efficacy and safety of once-daily etravirine-based regimen as a switching strategy in HIV-infected patients receiving a protease inhibitor-containing regimen. Etraswitch study
schema:name
Randomised study to assess the efficacy and safety of once-daily etravirine-based regimen as a switching strategy in HIV-infected patients receiving a protease inhibitor-containing regimen. Etraswitch study Randomised study to assess the efficacy and safety of once-daily etravirine-based regimen as a switching strategy in HIV-infected patients receiving a protease inhibitor-containing regimen. Etraswitch study Randomised study to assess the efficacy and safety of once-daily etravirine-based regimen as a switching strategy in HIV-infected patients receiving a protease inhibitor-containing regimen. Etraswitch study
p:P50
wds:Q35087745-AC810815-0F6A-47DB-A2E7-B02AAD6760D8 wds:Q35087745-BCAB8132-C920-4D4B-9214-C244A6589FD4 wds:Q35087745-377F74F7-1CAA-4428-898A-B3E725AFEC14 wds:Q35087745-3DB8A3FB-E958-4746-8D54-2E89F86F8D95 wds:Q35087745-400668E8-BB52-46DA-AAE4-D7AA1FE69D75 wds:Q35087745-51F559B1-CCF3-4D23-9B24-4DF2A90A7FDD wds:Q35087745-DCEE8B37-8B48-4B4A-A03A-A90630715B81 wds:Q35087745-E16FE53A-6BAA-4005-AF17-F6ADFDD65CB6 wds:Q35087745-F4ACC239-4D08-4140-AF44-F60C6C364B9C wds:Q35087745-FB19D184-4012-4FC8-8F05-9F332B78893C
wdt:P50
wd:Q114424202 wd:Q40375640 wd:Q20100355 wd:Q60556297 wd:Q114424206 wd:Q55948645 wd:Q47006508 wd:Q47006512 wd:Q90969786 wd:Q90969790
p:P1476
wds:Q35087745-70EEF219-A6CB-4DE8-9C6F-33C21DA33A39
wdt:P1476
Randomised study to assess the efficacy and safety of once-daily etravirine-based regimen as a switching strategy in HIV-infected patients receiving a protease inhibitor-containing regimen. Etraswitch study
p:P304
wds:Q35087745-5859A505-6055-4DB0-BBD2-19D8CF5D15F2
wdt:P304
e84676
p:P31
wds:Q35087745-A051DBDB-1910-4D37-8284-58D955D126E0
wdt:P31
wd:Q13442814
p:P698
wds:Q35087745-CCFBAE03-A6BB-4FE1-A963-F3FB9DE216AF
wdtn:P698
n12:24503952
wdt:P698
24503952
p:P1433
wds:Q35087745-9FD8378D-C844-4CCF-850D-F46FBDF698D2
wdt:P1433
wd:Q564954
p:P433
wds:Q35087745-6B24C385-B564-477C-8868-F3531CFC12D4
p:P478
wds:Q35087745-1A84B988-4A07-425C-B991-BC177F331A55
wdt:P433
2
wdt:P478
9
p:P356
wds:Q35087745-167CAF28-E03A-4AFD-B4DC-7B06CC1D77CA
wdtn:P356
n9:JOURNAL.PONE.0084676
wdt:P356
10.1371/JOURNAL.PONE.0084676
p:P275
wds:Q35087745-3fb3507c-2bb2-493e-9ff3-81e2842460d6
p:P6216
wds:Q35087745-d1ade4c6-a724-4a84-a200-b3ec7fb96676
wdt:P275
wd:Q20007257
wdt:P6216
wd:Q50423863
p:P5875
wds:Q35087745-481C2C4D-4AF5-458A-8AD6-8F9519F3E6FB
wdt:P5875
260120673
p:P819
wds:Q35087745-1B786DDA-2177-4C5A-94F3-2B337B255F0D
wdt:P819
2014PLoSO...984676E
p:P932
wds:Q35087745-2C511FEF-9DB0-4B17-A33B-286815B34F77
wdt:P932
3913576